Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LCMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ELP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZSCAN21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FANCI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSC22D3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYTH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ICAM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FOXN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBC1D7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHKB-CPT1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTOR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCM3AP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBC1D22B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOCS7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMARCE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZYG11B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C21orf33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on